Doramectin Impurity 2 CAS CATO-C4X-22092
| CAS No. | CATO-C4X-22092 |
| Molecular Formula | C50H76O14 |
| Molecular Weight | 901.13 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Doramectin Impurity 2 (C50H76O14) contains a carboxylic acid group, a hydroxyl group, an ether linkage, a polycyclic aromatic system. The carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
As a process- or degradation-related impurity, Doramectin Impurity 2 (CAS CATO-C4X-22092, C50H76O14) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Doramectin Impurity 2 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C50H76O14 |
| Molecular Weight | 901.13 g/mol |
| Purity | >95% |
| Storage | Store at room temperature, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, acetonitrile, DMSO, water (slightly soluble) |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 13.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
Related Doramectin Standards
Recommended Standards
- 22,23-Dihydro-25-cyclohexylavermectin B1 (CAS 142680-85-1)
- Biotin-PEG3-Bis-sulfone (CAS 2055048-58-1)
- Cadmate(4-), [[4,4',4'',4'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis[benzoato]](6-)-N21,N22,N23,N24]-, tetrahydrogen, (SP-4-1)- (9CI) (CAS 82404-76-0)
- 2,4,5,6-Tetrakis(3,6-dimethyl-9H-carbazol-9-yl)-1,3-benzenedicarbonitrile (CAS 1469703-61-4)
- Clevidipine butyrate Impurity 9 (CAS CATO-C4X-10159)
- Adenosine Impurity 22 (CAS 17236-65-6)
- Ondansetron EP Impurity F (CAS 693-98-1)
- 5,7-dimethylpyrido[2,3-d]pyrimidine-2,4-diamine (CAS 20739-23-5)
- 3-(4-Fluoro-2-methylbenzyl)piperidine hydrochloride (CAS 1172955-97-3)
- (R)-6'-Chloro-3',4,4',5-tetrahydro-2H,2'H-spiro[benzo[b][1,4]oxazepine-3,1'-naphthalene]-7-carboxylic acid (CAS 2763038-79-3)
- 2-Ethyl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-ol (CAS 104472-75-5)
- 3,6-Thioxanthenediamine-10,10-dioxide (CAS 10215-25-5)
- 2-(4-fluoro-5-methylfuran-3-yl)acetic acid (CAS 1513181-81-1)
- Gastrin Tetrapeptide (CAS 1947-37-1)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com